Hyeongjoo Kim
Overview
Explore the profile of Hyeongjoo Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
130
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim S, Kim H, Hong I, Lee M, Kim H, Kwak H, et al.
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076494
Globally, the mortality rate of colorectal cancer (CRC) remains high. Despite the development of various treatments, such as targeted therapy and immunotherapy, colorectal cancer continues to be a serious health...
2.
Kim H, Hong I, Roh S, Kim S, Kim H, Oh S, et al.
Oncol Rep
. 2023 Mar;
49(4).
PMID: 36866762
Colorectal cancer (CRC) is common cancer worldwide, and the 5‑year relative survival rate of CRC patients with distant metastasis is as low as 14%. Therefore, identifying markers of CRC is...
3.
Kim S, Kim D, Roh S, Hong I, Kim H, Ahn T, et al.
Biomedicines
. 2022 Mar;
10(3).
PMID: 35327428
Uncovering tumor markers of colorectal cancer is important for the early detection and prognosis of the patients. Spermine oxidase (SMOX) is upregulated in various cancers. The present study aims to...
4.
Kang D, Woo J, Kim H, Kim S, Ji S, Jaygal G, et al.
Int J Mol Sci
. 2020 Oct;
21(21).
PMID: 33114545
HJURP is a key factor for CENP-A deposition and maintenance in centromeres. The role of mis-regulation of histone chaperones in cancer initiation and progression has been studied. However, its role...
5.
Kim H, Kim T, Jaygal G, Woo J, Kim C, Baek M, et al.
Pathol Res Pract
. 2020 Jul;
216(8):153044.
PMID: 32703504
Introduction: microRNAs (miRNAs) are frequently dysregulated in many human cancers including colorectal cancer (CRC) and are useful candidate biomarkers in liquid biopsy of cancer for their stability in the blood....
6.
Lee J, Kim E, Lee J, Kim D, Kim H, Kim C, et al.
Cancer Cell Int
. 2020 Feb;
20:42.
PMID: 32042269
Background: Although major driver gene mutations have been identified, the complex molecular heterogeneity of colorectal cancer (CRC) remains unclear. Capicua (CIC) functions as a tumor suppressor in various types of...
7.
Jeong D, Kim H, Kim D, Ban S, Oh S, Ji S, et al.
Cancer Biomark
. 2019 Apr;
24(4):485-495.
PMID: 30932884
Defensin alpha 6 (DEFA6) is a member of the alpha defensin family of microbicidal and cytotoxic peptides that defend against bacteria and viruses. Here, we provide a novel function of...
8.
Lee J, Yun C, Han Y, Kim S, Jeong D, Kwon H, et al.
J Pineal Res
. 2018 Aug;
65(4):e12519.
PMID: 30091203
Melatonin suppresses tumor development. However, the exact relationship between melatonin and cancer stem cells (CSCs) is poorly understood. This study found that melatonin inhibits colon CSCs by regulating the PrP...
9.
Jeong D, Kim H, Kim D, Ban S, Oh S, Ji S, et al.
Oncol Rep
. 2018 Apr;
39(6):2829-2836.
PMID: 29658598
The protein kinase, membrane‑associated tyrosine/threonine 1 (PKMYT1) is known to inhibit precocious entry into mitosis by phosphorylating CDK1 at Thr14 and Tyr15 residues. However, the functional importance of PKMYT1 in...
10.
Jeong D, Kim H, Ban S, Oh S, Ji S, Kim D, et al.
J Cancer Res Clin Oncol
. 2017 Sep;
143(12):2493-2503.
PMID: 28875407
Purpose: Adjuvant chemotherapy (AC) is frequently considered in patients with high-risk stage II colorectal cancer (CRC). Among patients with stage II CRC who do not receive AC because they are...